Padbury G[au] - Search Results

Year	Number of Results
1985	1
1988	1
1992	1
1994	1
1996	2
1997	2
1998	2
1999	2
2007	1
2011	1
2012	1
2014	1
2022	0

1

Chemical reactivities of bleomycin.

Padbury G, Sligar SS. Padbury G, et al. J Biol Chem. 1985 Jul 5;260(13):7820-3. J Biol Chem. 1985. PMID: 2409076 Free article.

2

Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue.

Li LH, DeKoning TF, Kelly RC, Krueger WC, McGovren JP, Padbury GE, Petzold GL, Wallace TL, Ouding RJ, Prairie MD, et al. Li LH, et al. Among authors: padbury ge. Cancer Res. 1992 Sep 15;52(18):4904-13. Cancer Res. 1992. PMID: 1516047

3

Species-dependent enantioselective pharmacokinetics of PNU-103017, a pyrone HIV protease inhibitor.

Zhong WZ, Williams MG, Borin MT, Padbury GE. Zhong WZ, et al. Among authors: padbury ge. Chirality. 1998;10(3):210-6. doi: 10.1002/(SICI)1520-636X(1998)10:3<210::AID-CHIR2>3.0.CO;2-D. Chirality. 1998. PMID: 9499572 Clinical Trial.

4

Periglacial fires and trees in a continental setting of Central Canada, Upper Pleistocene.

Bélanger N, Carcaillet C, Padbury GA, Harvey-Schafer AN, Van Rees KJ. Bélanger N, et al. Among authors: padbury ga. Geobiology. 2014 Mar;12(2):109-18. doi: 10.1111/gbi.12076. Epub 2014 Jan 10. Geobiology. 2014. PMID: 24405713 Free article.

5

Model-based strategy for bioanalytical method comparison: measurement of a soluble ligand as a biomarker.

Thway TM, Wang J, Brunner LA, Gu W, Magana I, Padbury G, Ma M. Thway TM, et al. Among authors: padbury g. J Pharm Biomed Anal. 2012 Jan 25;58:65-70. doi: 10.1016/j.jpba.2011.09.004. Epub 2011 Sep 10. J Pharm Biomed Anal. 2012. PMID: 22005590

6

Bioactivation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-d]pyrimidine (U-89843) to reactive intermediates that bind covalently to macromolecules and produce genotoxicity.

Zhao Z, Koeplinger KA, Padbury GE, Hauer MJ, Bundy GL, Banitt LS, Schwartz TM, Zimmermann DC, Harbach PR, Mayo JK, Aaron CS. Zhao Z, et al. Among authors: padbury ge. Chem Res Toxicol. 1996 Dec;9(8):1230-9. doi: 10.1021/tx960092z. Chem Res Toxicol. 1996. PMID: 8951224

7

Increased lipophilicity and subsequent cell partitioning decrease passive transcellular diffusion of novel, highly lipophilic antioxidants.

Sawada GA, Barsuhn CL, Lutzke BS, Houghton ME, Padbury GE, Ho NF, Raub TJ. Sawada GA, et al. Among authors: padbury ge. J Pharmacol Exp Ther. 1999 Mar;288(3):1317-26. J Pharmacol Exp Ther. 1999. PMID: 10027873

8

Factors impacting the delivery of therapeutic levels of pyrone-based HIV protease inhibitors.

Padbury GE, Zipp GL, Schwende FJ, Zhao Z, Koeplinger KA, Chong KT, Raub TJ, Thaisrivongs S. Padbury GE, et al. Pharm Biotechnol. 1998;11:211-32. doi: 10.1007/0-306-47384-4_10. Pharm Biotechnol. 1998. PMID: 9760682 Review. No abstract available.

9

Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium.

Koeplinger KA, Raub TJ, Padbury GE, Zhao Z. Koeplinger KA, et al. Among authors: padbury ge. J Pharm Biomed Anal. 1999 Mar;19(3-4):399-411. doi: 10.1016/s0731-7085(98)00143-5. J Pharm Biomed Anal. 1999. PMID: 10704105

10

In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.

Zhao Z, Koeplinger KA, Bundy GL, Banitt LS, Padbury GE, Hauer MJ, Sanders PE. Zhao Z, et al. Among authors: padbury ge. Drug Metab Dispos. 1996 Feb;24(2):187-98. Drug Metab Dispos. 1996. PMID: 8742230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results